Altre lingue BioLargo, Inc.

Azioni

BLGO

US09065A1007

Tempo differito OTC Markets Altri mercati azionari 21:54:52 01/05/2024			Variaz. 5gg	Var. 1 gen.
0,3396 ^USD	+2,17%		-3,39%	+102,14%

02/04	Transcript : BioLargo, Inc., Q4 2023 Earnings Call, Apr 02, 2024
01/04	BioLargo, Inc. riporta i risultati degli utili per l'intero anno conclusosi il 31 dicembre 2023	CI

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

BioLargo, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	01/04
BioLargo to Present at The LD Micro Invitational XIV	25/03
New Regulations May Be Coming To Combat Dangerous “Forever Chemicals” – This Cleantech Innovator Is Ready	22/02
Biolargo Equipment Solutions & Technologies, Inc Appoints Sally Gutierrez to the Board of Directors	12/02
BioLargo, Inc. Launches Water Equipment Subsidiary to Capitalize on Opportunities in PFAS and Water Treatment	29/01
BioLargo, Inc. announced that it has received $0.815 million in funding	23/01
BioLargo's PFAS Removal Technology Lands Drinking Water Treatment Project in New Jersey	20/12
BioLargo, Inc. cancelled the transaction announced on December 13, 2022	13/12
BioLargo, Inc. announced that it expects to receive $0.815 million in funding	17/11
BioLargo, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
BioLargo, Inc. to Present at the LD Micro Main Event XVI	19/09/23
BioLargo, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23
BioLargo, Inc. Discusses Record-Breaking Financial Results, Innovation-Pipeline Business Model, and More with The Stock Day Podcast	05/06/23
BIOLARGO, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	18/05/23
BioLargo, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	17/05/23
0:00:05.7 Dennis Calvert: Today. What's up? Dennis Calvert - Form 8-K	09/05/23
BIOLARGO, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	09/05/23
BioLargo to Present at the Sequire Investor Summit in Puerto Rico	24/04/23
BIOLARGO, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)	04/04/23
BIOLARGO, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	31/03/23

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue BioLargo, Inc.

Azioni

BLGO

US09065A1007

Altre lingue

Filtri